12 Dec 2014

Bambec (Bambuterol) - United Kingdom

ATC: R03CC
RESPIRATORY SYSTEM
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
ADRENERGICS FOR SYSTEMIC USE
SELECTIVE BETA-2-ADRENORECEPTOR AGONISTS
Bambec

Generic Matches for Bambuterol (1)
BAMBEC

Last Updated on 12 Dec 2014 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Bambec Indication

Management of asthma, bronchospasm and/or reversible airways obstruction.

Bambec Generic Name

Bambuterol

Type

POM

Summary Product Characteristics (SPCs) Links
All SPC - Bambec (external site)
SPC - Bambec Tablets 10 mg (external site)
SPC - Bambec Tablets 20 mg (external site)

Related Learning Zones

COPD Knowledge Centre

COPD Knowledge Centre

The COPD Knowledge Centre has been designed to provide healthcare professionals with free access to educational materials and disease awareness information. This includes information on the epidemiology, pathophysiology and symptoms of COPD and the latest guidelines for the diagnosis, treatment and management of the disease.

COPD-specific resources such as videosguidelinesinfographics, materials for your patients, upcoming events, useful websites and symposium videos and materials from ATS 2015 are available free of charge.

Symptomatic Asthma Knowledge Centre

Symptomatic Asthma Knowledge Centre

Focusing on the lack of symptomatic control in patients with asthma, the new Symptomatic Asthma Learning Zone, consisting of a Disease Awareness section, is free to access for all epgonline.org members, and has been designed to provide them with the information they need to effectively manage the symptoms of their patients with asthma.

Selected content related to Bambec (Bambuterol)

Guidelines

Bambec Marketing Information

Bambec Generic Name
Bambuterol
Marketing Company
AstraZeneca UK Limited
Drug Type
POM
Date of Issue, Marketing Authority 04/08/1992

Related Drugs - Respiratory

Back to top